National Thalassemia Prevention Campaign: The Talotır Project
نویسندگان
چکیده
Duran Canatan1, Yeşim Aydınok2, Yurdanur Kılınç3, Zeynep Karakaş4, İlgen Şaşmaz3, Hilmi Apak5, Nazan Sarper6 1Mediterranean Blood Diseases Foundation, Hemoglobinopathy Diagnosis Center, Antalya, Turkey 2Ege University, Department of Pediatric Hematology, İzmir, Turkey 3Çukurova University, Department of Pediatric Hematology, Adana, Turkey 4İstanbul University, Çapa Medical Faculty, Department of Pediatric Hematology, İstanbul, Turkey 5İstanbul University, Cerrahpaşa Medical Faculty, Department of Pediatric Hematology, İstanbul, Turkey 6Kocaeli University, Department of Pediatric Hematology, Kocaeli, Turkey
منابع مشابه
Investigating the causes of Beta Thalassemia after Start of Prevention Program in Jiroft City during 2001-2015
Introduction: Beta thalassemia major is the most common genetic disease in the world. The most common areas of this disease in the world are known as the Thalassemia Belt, which also includes Iran. Kerman province (and especially south of Kerman) ranks first in Iran in terms of the prevalence of thalassemia carriers. Hence, the present study was conducted to investigate the causes of thala...
متن کاملConformity of Drug Abuse International Standards, Psychological and Sociologic Theories and Drug and Alcohol Use Prevention in Iran in 4 National Development Programs
Background: The international drug abuse standards were achieved by review of a vast meta-analysis in the world and released 2 years ago in Vienna. Review of national programs in recent 20 years and conformity of them is the main objective of this presentation. Methods: Based on research that was supported by UNODC and DCHQ, the demand reduction program in Iran at the mentioned time was studied...
متن کاملارزشیابی اقتصادی برنامه ملی پیشگیری از بتاتالاسمی ماژور در دانشگاه علوم پزشکی مازندران
Background and purpose: Thalassemia is a preventable genetic disorder that is a major health problem. It is now two decades since implementation of the national program for preventing β-thalassemia major in Iran. This study was conducted to compare the costs and results of this program from 2010 to 2014 in Mazandaran University of Medical Sciences. Materials and methods: Economic evaluation...
متن کاملMolecular Basis of α-Thalassemia in Iran
Alpha-thalassemia (α-thal) is probably the most prevalent monogenic condition in the world. Deletions are the most common types of mutations in α-thal, followed by point mutations and small insertion/deletion. In the context of national screening program for prevention of thalassemia and hemoglobinopathies in Iran, α-thal carriers have come to more attention. Therefore, the fr...
متن کاملThe Iran thalassemia prevention program: success or failure?
Abstract Background Iran is one of the countries located on the “thalassemia belt” and a thalassemia prevention program was approved in our country in 1995. Many different researchers have studied the success of this program with no unanimous findings. Material and Methods A comprehensive literature search was performed using PubMed, Web of Science, and Google Scholar databases in Farsi an...
متن کامل